Paid Clinical Trials Salem

Discover 1,010 paid clinical trials in Salem, Oregon. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 1,010

Lomustine with Temozolomide & RadiationTesting the Addition of the Chemotherapy Drug Lomustine (Gleostine) to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Methylated Glioblastoma

Recruiting

PHASE3

Sponsor:

NRG Oncology

Location:

Newberg OR, Tualatin OR, Portland OR, Gresham ORshow 269 more

Code:

NCT05095376

Conditions

Glioblastoma

Gliosarcoma

Eligibility Criteria

Sex: All

Age: 18 - 70

Healthy Volunteers: Not accepted

Interventions

Lomustine

Magnetic Resonance Imaging

Photon Beam Radiation Therapy

Questionnaire Administration

Temozolomide

Metabolic ImagingDeveloping a New Metabolic Imaging Approach (aMRI) for Evaluating Neurological Disease in Patients With Gliomas

Recruiting

Sponsor:

OHSU Knight Cancer Institute

Location:

Portland OR

Code:

NCT05937776

Conditions

Glioma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Fludeoxyglucose F-18

Gadoterate Meglumine

Contrast-enhanced Magnetic Resonance Imaging

Positron Emission Tomography

Cema-celConsolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

Recruiting

PHASE2

Sponsor:

Allogene Therapeutics

Location:

Portland OR, Eugene OR, Seattle WA, Sacramento CAshow 33 more

Code:

NCT06500273

Conditions

Large B-cell Lymphoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

cemacabtagene ansegedleucel

ALLO-647

Fludarabine

Cyclophosphamide

Foresight CLARITY™ IUO MRD test, powered by PhasED-Seq™

PembrolizumabLong-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

Recruiting

PHASE3

Sponsor:

Merck Sharp & Dohme LLC

Location:

Portland OR, Seattle WA, San Francisco CA, Stanford CAshow 68 more

Code:

NCT03486873

Conditions

Solid Tumors

Hematologic Malignancies

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Pembrolizumab

Standard of Care (SOC)

Lenvatinib

Olaparib

MK-4280

HLA TestingA Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Solid Tumors

Recruiting

Sponsor:

TScan Therapeutics, Inc.

Location:

Portland OR, San Diego CA, Scottsdale AZ, Minneapolis MNshow 13 more

Code:

NCT05812027

Conditions

Head and Neck Cancer

Cervical Cancer

Non Small Cell Lung Cancer

Melanoma

Ovarian Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Tumor and HLA Profiling

DupilumabA Trial to Learn if Dupilumab is Safe for and Helps Adult and Adolescent Participants With Eosinophilic Gastritis With or Without Eosinophilic Duodenitis

Recruiting

PHASE2

PHASE3

Sponsor:

Regeneron Pharmaceuticals

Location:

Portland OR, Seattle WA, Reno NV, San Francisco CAshow 42 more

Code:

NCT05831176

Conditions

Eosinophilic Gastritis

Eosinophilic Duodenitis

Eosinophilic Gastrointestinal Disease

Eligibility Criteria

Sex: All

Age: 12+

Healthy Volunteers: Not accepted

Interventions

Dupilumab Dose 1

Dupilumab Dose 2

Matching Placebo

Observational StudyOptimizing Research With Diverse Families - Feasibility and Acceptability Study (FAST)

Recruiting

Sponsor:

Oregon Health and Science University

Location:

Portland OR

Code:

NCT06133231

Conditions

Attention Deficit/Hyperactivity Disorder

Emotional Dysfunction

Irritable Mood

Eligibility Criteria

Sex: All

Age: 6 - 17

Healthy Volunteers: Not accepted

Interventions

Multinutrients; a 36-ingredient blend of vitamins, minerals, amino acids, and antioxidants

Ustekinumab & GuselkumabA Study of Ustekinumab or Guselkumab in Pediatric Participants With Active Juvenile Psoriatic Arthritis

Recruiting

PHASE3

Sponsor:

Janssen Research & Development, LLC

Location:

Portland OR, Salt Lake City UT, Los Angeles CA, Cincinnati OHshow 4 more

Code:

NCT05083182

Conditions

Arthritis, Juvenile

Eligibility Criteria

Sex: All

Age: 5 - 17

Healthy Volunteers: Not accepted

Interventions

Ustekinumab

Guselkumab

ElamipretideReNEW:Phase 3 Study of Efficacy, Safety & Pharmacokinetics of Subcutaneous Injections of Elamipretide in Subjects With Dry Age-Related Macular Degeneration (Dry AMD)

Recruiting

PHASE3

Sponsor:

Stealth BioTherapeutics Inc.

Location:

Portland OR, Silverdale WA, Sacramento CA, Walnut Creek CAshow 30 more

Code:

NCT06373731

Conditions

Age Related Macular Degeneration (ARMD)

Eligibility Criteria

Sex: All

Age: 55+

Healthy Volunteers: Not accepted

Interventions

Elamipretide

Placebo

Levonorgestrel IUDLevonorgestrel 52 mg IUD for Emergency Contraception and Same-Day Start

Recruiting

Sponsor:

University of Utah

Location:

Portland OR, Seattle WA, San Jose CA, Salt Lake City UTshow 4 more

Code:

NCT05444582

Conditions

Contraception

Eligibility Criteria

Sex: Female

Age: 16 - 35

Healthy Volunteers: Not accepted

Interventions

Levonorgestrel 52 MG Intrauterine System